Showing results (1021-1030 of 1,107) with videos related to

Sort By:
Pageof 111
Science Advances|December 23, 2022
Dating of a large tool assemblage at the Cooper's Ferry site (Idaho, USA) to ~15,785 cal yr B.P. extends the age of stemmed points in the AmericasLoren G Davis, David B Madsen, David A Sisson, et al.
Journal of Neuroscience Methods|November 24, 2012
Standardized database development for EEG epileptiform transient detection: EEGnet scoring system and machine learning analysisJonathan J Halford, Robert J Schalkoff, Jing Zhou, et al.
European Journal of Nutrition|July 5, 2023
Sugar and low/no-calorie-sweetened beverage consumption and associations with body weight and waist circumference changes in five European cohort studies: the SWEET projectMarion E C Buso, Elske M Brouwer-Brolsma, Novita D Naomi, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 8, 2014
Inter-rater agreement on identification of electrographic seizures and periodic discharges in ICU EEG recordingsJ J Halford, D Shiau, J A Desrochers, et al.
Oncogene|April 11, 2003
Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial casesPäivi Laiho, Tuija Hienonen, Auli Karhu, et al.
Obesity Facts|July 25, 2017
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health RiskJohannes Hebebrand, Jens-Christian Holm, Euan Woodward, et al.
Cell|November 17, 2009
Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppressionMaria Genander, Michael M Halford, Nan-Jie Xu, et al.
Nutrition Bulletin|April 6, 2021
Learning in lockdown: Using the COVID-19 crisis to teach children about food and climate changeA Kluczkovski, R Lait, C A Martins, et al.
Diabetes, Obesity & Metabolism|September 5, 2023
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE)Surya Panicker Rajeev, Carl Alexander Roberts, Emily Brown, et al.
The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.
Pageof 111